   <!--Fragment 02 -->
<table style="background-color:#dfe5e6;border:1px solid #558476;font-family: Arial" width="550">
    <tr>
        <td width="500" style="padding: 15px 25px;">
            <p style="font-size:16px;color:#558476;margin-bottom: 0">ALL treatment regimens are complex and require supportive care measures </p>
            <p style="font-size:26px;font-weight:bold;color:#558476;margin-top: 7px;margin-bottom:0">The NCCN ALL Panel recommends that patients be treated at a specialized cancer center with expertise in the management of ALL<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">{{CitationNumber[1]}}</sup></p>
            <p style="font-size:16px;font-weight:bold;color:#333333;margin-top:12px;margin-bottom:0px">
                Specialized centers for B-ALL
            </p>
            <table style="font-family: arial; font-size: 16px; color: #333333;" border="0">
                <tr>
                    <td style="color:#558476; vertical-align: top">&#x25cf;</td>
                    <td style="line-height: 1.333;color: #333333;">Treat a high volume of ALL patients</td>
                </tr>
                <tr>
                    <td style="color:#558476; vertical-align: top">&#x25cf;</td>
                    <td style="color: #333333;">Generally perform at least 10 transplants each year and have a dedicated transplant team of specialists and nurses<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">{{CitationNumber[2]}}</sup></td>
                </tr>
                <tr>
                    <td style="color:#558476; vertical-align: top">&#x25cf;</td>
                    <td style="color: #333333;">The transplant team is trained in the performance and management of hematopoietic transplants<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">{{CitationNumber[2]}}</sup></td>
                </tr>
            </table>
<br>
            
            
                                <table  cellspacing="0" cellpadding="0" bgcolor="#558476" align="center" style=";margin-bottom:10px">
                        
                        <tr><td align="center" style="font-family: arial; padding:15px;padding-bottom:15px;"> <a href="http://www.understandingall.com/epidemiologyandetiology.html" target="_blank" style="font-size:22px;color:#eece11;text-decoration:none;vertical-align:middle;"><strong>Find out more about the NCCN Guidelines &gt;</strong></a></td></tr>
                    </table>
            
            
            
            
        </td>
    </tr>
</table>
{{CitationStart}}
<br><strong>{{CitationNumber[1]}}.</strong> References with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">&reg;</sup>) for Acute Lymphoblastic Leukemia V.1.2014. Â© National Comprehensive Cancer Network, Inc 2014. All rights reserved. Accessed July 8, 2014. To view the most recent and complete version of the guidelines, go online to NCCN.org. NATIONAL COMPREHENSIVE CANCER NETWORK<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">&reg;</sup>, NCCN<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">&reg;</sup>, NCCN GUIDELINES<sup style="font-size: 70%; line-height: 0; position: relative; top: 0.5em; vertical-align: text-top">&reg;</sup>, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.
<br><strong>{{CitationNumber[2]}}.</strong> Philips G, Armitage J, Bearman S, et al. <em>Biol Blood Marrow Transplant. 1995;1:54-55.
{{CitationEnd}}
